Remdesivir in covid-19.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 32321732)

Published in BMJ on April 22, 2020

Authors

Robin E Ferner1, Jeffrey K Aronson2

Author Affiliations

1: Institute of Clinical Sciences, University of Birmingham, Birmingham, UK r.e.ferner@bham.ac.uk.
2: Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Articles cited by this

Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med (2020) 5.15